Clinical Trials · NCT00603239
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 165
- Start date
- Jan 2008
- Locations
- 25 sites, 5 countries
- Primary endpoint
- Change in Glycosylated Hemoglobin (HbA1c)